Physicians Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Physicians Financial Services’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$249K	Hold	400	–	–	0.06%	102
2026 Q1	$309K	Hold	400	–	–	0.08%	93
2025 Q4	$309K	Hold	400	–	–	0.08%	91
2025 Q3	$225K	Hold	400	–	–	0.06%	104
2025 Q2	$210K	Buy	400 +15	+4%	+$8.37K	0.06%	107
2025 Q1	$244K	Hold	385	–	–	0.08%	99
2024 Q4	$274K	Hold	385	–	–	0.08%	94
2024 Q3	$405K	Sell	385 -10	-3%	-$11.1K	0.13%	86
2024 Q2	$415K	Hold	395	–	–	0.14%	88
2024 Q1	$380K	Hold	395	–	–	0.13%	88
2023 Q4	$347K	Hold	395	–	–	0.13%	88
2023 Q3	$325K	Hold	395	–	–	0.13%	91
2023 Q2	$284K	Hold	395	–	–	0.11%	98
2023 Q1	$325K	Hold	395	–	–	0.14%	92
2022 Q4	$285K	Hold	395	–	–	0.13%	98
2022 Q3	$272K	Hold	395	–	–	0.13%	94
2022 Q2	$233K	Hold	395	–	–	0.1%	105
2022 Q1	$276K	Buy	395 +40	+11%	+$25.3K	0.11%	106
2021 Q4	$224K	Hold	355	–	–	0.08%	113
2021 Q3	$215K	Buy	+355	New	+$220K	0.09%	114
2017 Q1	–	Sell	-100	Closed	-$41K	–	224
2016 Q4	$41K	Buy	+100	New	+$38K	0.03%	170
2016 Q3	–	Sell	-100	Closed	-$35K	–	309
2016 Q2	$35K	Hold	100	–	–	0.03%	175
2016 Q1	$36K	Hold	100	–	–	0.03%	168
2015 Q4	$54K	Buy	+100	New	+$54.2K	0.05%	162

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Physicians Financial Services's REGN Position: Q2 2026 in Review

Physicians Financial Services held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 400 shares worth $249K. The position accounts for 0.06% of the portfolio, ranked #102.

Physicians Financial Services first reported a position in REGN in Q4 2015 and has held it in 24 quarters since. The position peaked at $415K in Q2 2024. 374 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Physicians Financial Services held 400 shares of Regeneron Pharmaceuticals worth $249K as of Q2 2026.
Physicians Financial Services left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up 0.06% of Physicians Financial Services's portfolio in Q2 2026, its #102 holding.
Physicians Financial Services first reported a position in Regeneron Pharmaceuticals in Q4 2015 and has held it in 24 quarters since.
Physicians Financial Services's Regeneron Pharmaceuticals position peaked at $415K in Q2 2024.
374 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Physicians Financial Services's 13F filing for Q2 2026, filed 21 Jul 2026.